Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPγ (Ig/EBP)

被引:59
作者
Parkin, SE
Baer, M
Copeland, TD
Schwartz, RC
Johnson, PF [1 ]
机构
[1] NCI Frederick, Basic Res Lab, Regulat Cell Growth Lab, Frederick, MD 21702 USA
[2] NCI Frederick, Basic Res Lab, Eukaryot Transcript Regulat Sect, Frederick, MD 21702 USA
[3] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA
关键词
D O I
10.1074/jbc.M202184200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The CCAAT/enhancer-binding proteins (C/EBPs) are basic leucine zipper transcription factors that play important roles in regulating cell growth and differentiation. C/EBP proteins form leucine zipper-mediated homodimers but are also capable of heterodimerizing with other C/EBPs in vitro. Here we show that C/EBPbeta occurs predominantly as a heterodimer that displays rapid mobility in gel shift assays. Biochemical fractionation and antibody supershift assays demonstrate that the C/EBPbeta heterodimeric partner is C/EBPgamma (Ig/EBP), a C/EBP protein that has been implicated as an inhibitor of other family members. Although most cell types express C/EBPbeta.C/EBPgamma heterodimers, macrophages contain a C/EBPbeta partner that is serologically distinct from C/EBPgamma. We found that C/EBPgamma blocked the ability of C/EBPbeta and C/EBPgamma to activate a reporter gene in L cell fibroblasts but did not inhibit a chimeric C/EBPbeta protein containing the GCN4 leucine zipper. Repression by C/EBPgamma occurs at the level of transactivation and requires heterodimerization with the C/EBP partner. C/EBPgamma was an ineffective repressor in HepG2 hepatoma cells despite forming C/EBP heterodimers, and C/EBPalpha was not effectively inhibited in either L or HepG2 cells. Our findings demonstrate that C/EBPgamma modulates C/EBP activity in a cell- and isoform-specific manner.
引用
收藏
页码:23563 / 23572
页数:10
相关论文
共 51 条
  • [1] A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY
    AKIRA, S
    ISSHIKI, H
    SUGITA, T
    TANABE, O
    KINOSHITA, S
    NISHIO, Y
    NAKAJIMA, T
    HIRANO, T
    KISHIMOTO, T
    [J]. EMBO JOURNAL, 1990, 9 (06) : 1897 - 1906
  • [2] An MR, 1996, MOL CELL BIOL, V16, P2295
  • [3] Generation of truncated C/EBPβ isoforms by in vitro proteolysis
    Baer, M
    Johnson, PF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) : 26582 - 26590
  • [4] C/EBP-RELATED PROTEIN-2 CONFERS LIPOPOLYSACCHARIDE-INDUCIBLE EXPRESSION OF INTERLEUKIN-6 AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 TO A LYMPHOBLASTIC CELL-LINE
    BRETZ, JD
    WILLIAMS, SC
    BAER, M
    JOHNSON, PF
    SCHWARTZ, RC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) : 7306 - 7310
  • [5] LAP (NF-IL-6), A TISSUE-SPECIFIC TRANSCRIPTIONAL ACTIVATOR, IS AN INHIBITOR OF HEPATOMA-CELL PROLIFERATION
    BUCK, M
    TURLER, H
    CHOJKIER, M
    [J]. EMBO JOURNAL, 1994, 13 (04) : 851 - 860
  • [6] Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBPβ is required for hepatocyte proliferation induced by TGFα
    Buck, M
    Poli, V
    van der Geer, P
    Chojkier, M
    Hunter, T
    [J]. MOLECULAR CELL, 1999, 4 (06) : 1087 - 1092
  • [7] C/EBPα is critical for the neonatal acute-phase response to inflammation
    Burgess-Beusse, BL
    Darlington, GJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 7269 - 7277
  • [8] REGULATED EXPRESSION OF 3 C/EBP ISOFORMS DURING ADIPOSE CONVERSION OF 3T3-L1 CELLS
    CAO, ZD
    UMEK, RM
    MCKNIGHT, SL
    [J]. GENES & DEVELOPMENT, 1991, 5 (09) : 1538 - 1552
  • [9] IG/EBP (C/EBP-GAMMA) IS A TRANSDOMINANT NEGATIVE INHIBITOR OF C/EBP FAMILY TRANSCRIPTIONAL ACTIVATORS
    COOPER, C
    HENDERSON, A
    ARTANDI, S
    AVITAHL, N
    CALAME, K
    [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (21) : 4371 - 4377
  • [10] COOPER C, 1992, J IMMUNOL, V149, P3225